Arteriolar reactivity in conscious diabetic rats: Influence of aminoguanidine treatment

Diabetes

Volumn 47, Issue 6, 1998, Pages 918-923

  Crijns, Francy R L ^a,b   Struijker Boudier, Harry A J ^a   Wolffenbuttel, Bruce H R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMINOGUANIDINE; ANGIOTENSIN; LEMAKALIM; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG SCREENING; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; ARTERIOLES; BLOOD GLUCOSE; BLOOD PRESSURE; CONSCIOUSNESS; CROMAKALIM; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GUANIDINES; HEMOGLOBIN A, GLYCOSYLATED; MALE; MICROCIRCULATION; MUSCLE, SKELETAL; NOREPINEPHRINE; POTASSIUM CHANNELS; RATS; RATS, WISTAR; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0031860074     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.6.918     Document Type: Article

References (32)

1. Lash JM, Bohlen HG: Structural and functional origins of suppressed acetylcholine vasodilation in diabetic rat intestinal arterioles. Circ Res 69:1259-1268, 1991
2. Mayhan WG, Simmons LK, Sharpe GM: Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol 260:H319-H326, 1991
3. Hill MA, Ege EA: Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats: effect of aminoguanidine treatment. Diabetes 43:1450-1456, 1994
4. Morff RJ: Microvascular reactivity to norepinephrine at different arteriolar levels and durations of streptozocin-induced diabetes. Diabetes 39:354-360, 1990
5. Hill MA, Larkins RG: Altered microvascular reactivity in streptozotocin-induced diabetes in rats. Am J Physiol 257:H1438-H1445, 1989
6. Le Noble JL, Struijker Boudier HAJ, Smits JFM: Differential effects of general anesthetics on regional vasoconstrictor responses in the rat. Arch Int Pharmacodyn Ther 289:82-92, 1987
7. Gilbert M, Roberts SL, Mori M, Blomberg R, Tinker JH: Comparative coronary vascular reactivity and hemodynamics during halothane and isoflurane anesthesia in swine. Anesthesiology 68:243-253, 1988
8. Kiff RJ, Gardiner SM, Compton AM, Bennett T: Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 103:1357-1362, 1991
9. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991
10. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-556, 1992
11. Huijberts MSP, Wolffenbuttel BHR, Struijker Boudier HAJ, Crijns FRL, Nieuwenhuijzen Kruseman AC, Poitevin P, Lévy BI: Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest 92:1407-1411, 1993
12. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88:11555-11558, 1991
13. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, Williamson JR: Prevention of diabetic vascular dysfunction by guanidines: inhibition of nitric oxide synthase versus advanced glycosylation end product formation. Diabetes 42:221-232, 1993
14. Smith TL, Osborne SW, Hutchins PM: Long-term micro- and macro-circulatory measurements in conscious rats. Microvasc Res 29:360-370, 1985
15. Le Noble JL, Smith TL, Hutchins PM, Struijker Boudier HAJ: Microvascular alterations in adult conscious spontaneously hypertensive rats. Hypertension 15:415-419, 1990
16. Struijker Boudier HAJ, Messing MWJ, van Essen H: Preferential small arteriolar vasodilatation by the potassium channel opener, BRL 38227, in conscious spontaneously hypertensive rats. Eur J Pharmacol 218:191-193, 1992
17. Messing M, Van Essen H, Smith TL, Smits JFM, Struijker Boudier HAJ: Microvascular actions of calcium channel antagonists. Eur J Pharmacol 198:189-195, 1991
18. Messing MWJ, van Essen H, Struijker Boudier HAJ: Effects of alfa-adrenoreceptor antagonists on striated muscle microcirculation of conscious rats. Drugs 40 (Suppl. 4):31-33, 1990
19. Struijker Boudier HAJ, Messing MWJ, van Essen H: Alpha-adrenergic reactivity of the microcirculation in conscious spontaneously hypertensive rats. Mol Cell Biochem 157:239-244, 1996
20. Yu Z, McNeill JH: Blood pressure and heart rate response to vasoactive agents in conscious diabetic rats. Can J Physiol Pharmacol 70:1642-1548, 1992
21. Jackson CV, Carrier GO: Influence of short-term experimental diabetes on blood pressure and heart rate in response to norepinephrine and angiotensin II in the conscious rat. J Cardiovasc Pharmacol 5:260-265, 1983
22. Calver A, Collier J, Vallence P: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548-2554, 1992
23. Halkin A, Benjamin N, Doktor HS, Todd SD, Viberti G, Ritter JM: Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin Sci (Colch) 81:223-232, 1991
24. Huvers FC, de Haan CHA, Houben AJHM, de Leeuw PW, Schaper NC: The elevated blood pressure in insulin-dependent diabetes mellitus patients with microalbuminuria is not caused by changes in adrenoceptor activity (Abstract). Neth J Med 48:A74, 1996
25. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thien T: Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes 42:148-153, 1993
26. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes-mellitus. Circulation 88:2510-2516, 1993
27. Mayhan WG: Effect of diabetes mellitus on response of the basilar artery to activation of ATP-sensitive potassium channels. Brain Res 636:35-39, 1994
28. Mayhan WG, Faraci FM: Responses of cerebral arterioles in diabetic rats to activation of ATP-sensitive potassium channels. Am J Physiol 265:H152-H157, 1993
29. Standen NB, Quale JM, Davis NW, Brayden JE, Huang Y, Nelson TM: Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 245:177-180, 1989
30. Bauersachs J, Hecker M, Busse R: Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 113:1548-1553, 1994
31. Endo K, Abiru T, Machida H, Kasua Y, Kamata K: Endothelium-derived hyperpolarizing factor does not contribute to the decrease in endothelium-dependent relaxation in the aora of streptozotocin-induced diabetic rats. Gen Pharmacol 26:149-153, 1995
32. Hwa JJ, Ghibaudi L, Williams P, Chatterjee M: Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular beds. Am J Physiol 266:H952-H958, 1994